Corient Capital Partners, LLC Perkinelmer Inc Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Perkinelmer Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 1,659 shares of PKI stock, worth $200,739. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,659
Previous 1,659
-0.0%
Holding current value
$200,739
Previous $236,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding PKI
# of Institutions
567Shares Held
110MCall Options Held
179KPut Options Held
66.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD18MShares$2.18 Billion1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$1.71 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY8.78MShares$1.06 Billion0.02% of portfolio
-
Select Equity Group, L.P. New York, NY7.37MShares$892 Million3.66% of portfolio
-
Janus Henderson Group PLC London, X06.23MShares$753 Million0.41% of portfolio
About PERKINELMER INC
- Ticker PKI
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 126,224,000
- Market Cap $15.3B
- Description
- PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...